Hikma Pharmaceutical | L'Utile Operativo



Operating Profit Cambiamento Data
Almirall EUR 53.03M 68.53M 2024-06
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Autolus Therapeutics Ltd -75864000 7.99M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Fresenius EUR 469M 23M 2024-12
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 2.19B 89M 2024-12
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Orion EUR 77.9M 14.8M 2025-03
Recordati EUR 162.68M 13.82M 2024-09
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 163M 39M 2024-06



Hikma Pharmaceutical L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.